Ignite Creation Date:
2025-12-24 @ 11:48 AM
Ignite Modification Date:
2026-05-27 @ 1:10 PM
Study NCT ID:
NCT06059261
Status:
RECRUITING
Last Update Posted:
2024-08-06
First Post:
2023-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
Sponsor:
Chongqing University Cancer Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Nasopharyngeal Carcinoma | View |
Keywords: